NTLA
Intellia Therapeutics, Inc. · Healthcare · Market cap $1.7B
Insiders sold $310K net in the last 90 days ·2 sellers, 0 buyers· 2 of 3 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 6, 2026
Insider Buying
$1.4M
reported purchases (SEC code P)
Insider Selling
$2.2M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Oct 28, 2026
Dube Michael P
Intellia Therapeutics, Inc. (NTLA) has 29 SEC Form 4 filings (36 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Oct 28, 2026.
Inside the rolling window, 8 insiders at Intellia Therapeutics, Inc. reported 1 open-market purchase totaling $1.4M and 16 open-market sales totaling $2.2M. The most active filer is President and CEO LEONARD JOHN M with 4 filings. Insiders have net sold $530K over the trailing 6 months. The most recent open-market filing is a sale of 1,864 shares by VP, Chief Accounting Officer Dube Michael P, dated Oct 2, 2026, worth $23K.
- Industry:Biotechnology
- CEO:John Leonard
- Employees:377
- HQ:Cambridge, MA, US
- IPO:2016-05-06
| Source | |||||||
|---|---|---|---|---|---|---|---|
Dube Michael PFirst in 3 months | VP, Chief Accounting Officer | Sale | 1,864 | $23K | Oct 6 | +0.8% | SEC ↗ |
LEONARD JOHN MFirst in 8 months | President and CEO | Sale | 19,890 | $251K | Aug 24 | -0.7% | SEC ↗ |
LEONARD JOHN MFirst in 8 months | President and CEO | Sale | 2,785 | $36K | Aug 24 | -0.7% | SEC ↗ |
| EVP, Chief Financial Officer | Sale | 8,111 | $91K | Jul 24 | +16.9% | SEC ↗ | |
Dulac Edward J IIIFirst in 6 months | EVP, Chief Financial Officer | Sale | 4,677 | $84K | Jul 6 | -30.1% | SEC ↗ |
Dube Michael PFirst in 6 months | VP, Chief Accounting Officer | Sale | 2,641 | $44K | Jul 6 | -30.1% | SEC ↗ |
| EVP, Chief Technical Officer | Sale | 607 | $8K | Mar 3 | -8.3% | SEC ↗ | |
| EVP, General Counsel | Sale | 1,211 | $17K | Mar 3 | -8.3% | SEC ↗ | |
Cohen Fred EFirst filing | Director | Purchase | 150,000 | $1.4M | Jan 7 | +23.1% | SEC ↗ |
Clark ElianaFirst filing | EVP, Chief Technical Officer | Sale | 9,515 | $88K | Jan 7 | +23.1% | SEC ↗ |
BASTA JAMESFirst filing | EVP, General Counsel | Sale | 10,397 | $96K | Jan 7 | — | SEC ↗ |
Dulac Edward J IIIFirst filing | EVP, Chief Financial Officer | Sale | 6,379 | $59K | Jan 7 | — | SEC ↗ |
Dube Michael PFirst filing | VP, Chief Accounting Officer | Sale | 2,989 | $28K | Jan 7 | — | SEC ↗ |
Lebwohl DavidFirst filing | EVP, Chief Medical Officer | Sale | 11,903 | $110K | Jan 7 | — | SEC ↗ |
Schultes Birgit CFirst filing | EVP, Chief Scientific Officer | Sale | 8,508 | $78K | Jan 7 | — | SEC ↗ |
| President and CEO | Sale | 34,146 | $314K | Jan 7 | — | SEC ↗ | |
LEONARD JOHN MFirst filing | President and CEO | Sale | 88,146 | $836K | Dec 12 | — | SEC ↗ |
Congress trading NTLA 15 all-time
- DSen. Thomas Richard CarperOther$1,001 - $15,0002023-08-25
- DSen. Thomas Richard CarperPurchase$1,001 - $15,0002023-05-22
- DRep. Donald Sternoff BeyerOther$15,001 - $50,0002022-02-28
- DRep. Donald Sternoff BeyerOther$1,001 - $15,0002021-10-29
- DRep. Donald Sternoff BeyerOther$1,001 - $15,0002021-09-20
- DRep. Donald Sternoff BeyerOther$1,001 - $15,0002021-07-21
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does NTLA have?
Intellia Therapeutics, Inc. (NTLA) has 29 SEC Form 4 filings (36 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Oct 28, 2026.
When was the most recent SEC Form 4 filing for NTLA?
The most recent Form 4 filing for NTLA on Tracefour is dated Oct 28, 2026.
Who is the most active insider at NTLA?
The most active SEC Form 4 filer at NTLA in the rolling window is President and CEO LEONARD JOHN M, with 4 filings.
What is the net insider flow at NTLA over the last 6 months?
Over the trailing 180 days, insiders at NTLA have net sold $530K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at NTLA in the current window?
Inside the rolling window, insiders at NTLA bought $1.4M and sold $2.2M based on SEC Form 4 filings.
Can I get alerts for NTLA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Intellia Therapeutics, Inc. (NTLA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Intellia Therapeutics, Inc. is in the Healthcare sector.